Journals / Ege Pediatri Bülteni / 2003 / Cilt: 10 - Sayı: 3

Pulmonary alveolar proteinosis: A case report

Pulmoner alveolar proteinozisli bir olgu

Pages
151–154
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case was presented because of its rarety.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary alveolar proteinosis (PAP) is a rare chronic interstitial lung disease of unknown etiology characterized by accumulation of surfactant lipids and proteins in the alveoli and distal airways.
📊
Key Findings & Data:It was first described in 1958.
💡
Conclusion & Impact:This case was presented because of its rarety.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare chronic interstitial lung disease of unknown etiology characterized by accumulation of surfactant lipids and proteins in the alveoli and distal airways. It was first described in 1958. Although the pathogenesis of primary or idiopathic PAP remains unknown, it has been proposed that a loss of responsiveness of the monocyte-macrophage lineage to granulocyte-macrophage colony stimulating factor (GM-CSF) is involved in PAP. Thirteen month old boy was admitted to the emergency department because of dyspnea and cyanosis. From the history, we learned that he was admitted to the hospital for several times because of cough and cyanosis. With the laboratory and the radiolodical features, tha disease was taught that "interstitial lung disease". The histopathological examination of the lung biopsy material was reported as "pulmonary alveolar proteinosis". This case was presented because of its rarety.

Özet

Pulmoner alveolar proteinozis (PAP), surfaktan lipid ve proteinlerin alveoller ve distal hava yolunda birikimi ile karakterize etiyolojisi bilinmeyen nadir bir interstisyel akciğer hastalığıdır. İlk kez 1958'de tanımlanmıştır. Hastalığın primer formunun patogenezi tam olarak bilinmemekle beraber, monosit-makrofaj sisteminin granülosit-makrofaj koloni stimule edici faktöre (GM-CSF) cevapsızlığının yattığı düşünülmektedir. 13 aylık erkek olgu nefes almada zorluk ve morarma yakınması ile acil servise yatırıldı. Hikayesinde, 6 aylıktan itibaren tekrarlayan öksürük ve morarma şikayetleri ile hastaneye yatışının olduğu öğrenilen olgunun yapılan laboratuvar ve radyolojik incelemelerinde, interstisyel akciğer hastalığı düşünüldü. Yapılan akciğer biyopsisinin histopatolojik incelemesi sonucu pulmoner alveolar proteinozis lehine gelmesi üzerine nadir görülmesi nedeni ile sunuldu.

🔖

Cite This Article

ECEVİT, Ç., APA, H., HIZARCIOĞLU, M., KAYSERİLİ, E., GÜLEZ, P., ORTAÇ, R. (2022). Pulmonary alveolar proteinosis: A case report. Ege Pediatri Bülteni, Cilt: 10 - Sayı: 3, 151–154. https://ajindex.com/articles/495831

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Briens E, Delaval P, Mairesse MP, Valeyra D, Wallaert B, Lazor R, Cordier JF. Pulmonary Alveolar proteinosis. Rev Mal Respir 2002; 19 (2): 166-182
  2. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002: 15; 166 (2): 215-235
  3. Acosta O, Marenes I, Perez A, Hernandez AI, Bello MD, Lopez Y. Therapeutic efficacy of GM-CSF in pulmonary alveolar proteinosis. Arch Bronconeumol 2002; 38 (4): 191-193
  4. Wang X, Liu F, Bewing B. Analysis of the GM-CSF and GM-CSF/IL-3/IL-5 receptor common beta chain in a patient with pulmonary alveolar proteinosis. Clin Med J (Engl) 2002; 115 (1): 76-80
  5. Nakamura T, Ogasawara T, Shinjo K, Sako C, Suziki M. Pulmonary alveolar proteinosis successfully treated by modified lavage technique using high frequency jet ventilation. Nihon Kokyuki Gakkai Zasshi 2001; 39 (7): 514-518
  6. Mazzone P, Thomassen MJ, Kavuru M. Our new understanding of pulmonary alveolar protenosis: what an internist needs to know. Cleve Clin J Med 2001; 68 (12) 977-978, 981-982, 984-985
  7. Jansa P, Stritesky M, Homolko J. Pulmonary alveolar protenosis and its treatment with total pulmonary lavage in the Czech Republic. Vnitr Lek 2002; 48 (1): 34-37
  8. Holbert JM, Costello P, Li W, Hoffman RM, Rogers RM. CT features of pulmonary alveolar proteinosis. Am J Roentgenol 2001; 176 (5): 1287-1294
  9. Schoch OD, Schanz U, Koller M, Nakata K, Seymour JF, Russi EW, Boehler A. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Thorax 2002; 57 (3): 277-280.